MR [Mindray Medical International] CORRESP: (Original Filing)

[June 18, 2012 Mr. Martin James Senior Assistant Chief Accountant Division of Corporation Finance 100 F Street, NE Re: Mindray Medical International Limited Form 20-F for the Fiscal Year Ended December 31, 2011 Filed April 30, 2012 File No. 001-33036 Dear Mr. James: Company Comment Letter 2011 Form 20-F Commission On behalf of Mindray Medical International Limited (the “ Staff]

MR [Mindray Medical International] CORRESP: June 18, 2012 Mr. Martin James Senior Assistant

[June 18, 2012 Mr. Martin James Senior Assistant Chief Accountant Division of Corporation Finance 100 F Street, NE Re: Mindray Medical International Limited Form 20-F for the Fiscal Year Ended December 31, 2011 Filed April 30, 2012 File No. 001-33036 Dear Mr. James: Company Comment Letter 2011 Form 20-F Commission On behalf of Mindray Medical International Limited (the “ Staff]

MR [Mindray Medical International] CORRESP: (Original Filing)

[June18, 2012 Mr.Martin James Seniorsistant Chief Accountant Division ofrporation Finance 100 F Street, NE Re: Mindray Medical International Limited Form 20-F for the Fiscal Year Ended December31, 2011 Filed April30, 2012 File No.001-33036 Dear Mr.James:mpanymment Letter 2011 Form 20-Fmmission On behalf of Mindray Medical International Limited (the]

MR [Mindray Medical International] CORRESP: June18, 2012 Mr.Martin James Seniorsistant Chief Accountant Division

[June18, 2012 Mr.Martin James Seniorsistant Chief Accountant Division ofrporation Finance 100 F Street, NE Re: Mindray Medical International Limited Form 20-F for the Fiscal Year Ended December31, 2011 Filed April30, 2012 File No.001-33036 Dear Mr.James:mpanymment Letter 2011 Form 20-Fmmission On behalf of Mindray Medical International Limited (the]

DSWL [DESWELL INDUSTRIES] 6-K: (Original Filing)

[Deswell Announces Fourth Quarter Results - Company Announces Fourth Quarter Cash Dividend of $0.05 Per Share And - - A Special Cash Dividend of $0.10 Per Share - MACAO (June 18, 2012) - Deswell Industries, Inc. (Nasdaq: DSWL) today announced its financial results for the fiscal fourth quarter ended March 31, 2012. Net sales for the fourth quarter ended March]

By | 2016-03-02T03:10:43+00:00 June 18th, 2012|Categories: Chinese Stocks, DSWL, SEC Original|Tags: , , , , , |0 Comments

DSWL [DESWELL INDUSTRIES] 6-K: Deswell Announces Fourth Quarter Results – Company Announces

[Deswell Announces Fourth Quarter Results - Company Announces Fourth Quarter Cash Dividend of $0.05 Per Share And - - A Special Cash Dividend of $0.10 Per Share - MACAO (June 18, 2012) - Deswell Industries, Inc. (Nasdaq: DSWL) today announced its financial results for the fiscal fourth quarter ended March 31, 2012. Net sales for the fourth quarter ended March]

By | 2016-03-02T03:12:27+00:00 June 18th, 2012|Categories: Chinese Stocks, DSWL, Webplus ver|Tags: , , , , , |0 Comments

SFUN [SouFun] 6-K: (Original Filing)

[This Form 6-K sets forth our unaudited financial results as of and for the three months ended March 31, 2012 and a discussion of these results which we previously publicly released on May 15, 2012. We have also included, as required by Financial Accounting Standards Board’s (FASB) Accounting Standards Codification (ASC) 220 Comprehensive Income effective for 2012, a table which]

CCCL [China Ceramics] 6-K: (Original Filing)

[Investor Presentation June 2012 China Ceramics - Overview » Founded as Jinjiang Hengda Ceramics in 1993 » Manufactures six different types of ceramics tiles used for exterior siding » Ceramic tile market growth correlates with the strong urbanization and construction trends in China » Plant capacity to increase by 90% to 72 MM square meters by the end of 3Q] []

By | 2016-03-21T17:39:00+00:00 June 18th, 2012|Categories: CCCL, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

MR [Mindray Medical International] CORRESP: Confidential Treatment Requested By Mindray Medical International Limitednfidential

[Confidential Treatment Requested By Mindray Medical International Limitednfidential Informationnfidential Material In accordance with Rule 83, this Letter hasso been clearly marked with the legendnfidential Treatment Requested by Mindray Medical International Limited and each page is marked for the record with the identifying numbers andde M-1 through M-9.]

SFUN [SouFun] 6-K: This Form 6-K sets forth our unaudited financial

[This Form 6-K sets forth our unaudited financial results as of and for the three months ended March 31, 2012 and a discussion of these results which we previously publicly released on May 15, 2012. We have also included, as required by Financial Accounting Standards Board’s (FASB) Accounting Standards Codification (ASC) 220 Comprehensive Income effective for 2012, a table which]

Skip to toolbar